Market Overview
The Blue’s market intelligence desk — sector analysis, deal-flow trends and longevity research for founders, funds and operators in the longevity economy.
01AI in Predictive Analytics for MedTech: How Investors Evaluate ROI in 2026→02Rising Investment in Home Diagnostics and Remote Monitoring: From Telemedicine to Self-Care Devices→03Neurotechnology and BCI as a Hidden Gem: A Market on the Brink of Expansion→04Clinical AI Under Regulation: Why Validated Market Pathways Win in 2026→05National Health Data Infrastructures and Predictive Analytics: A New Asset Class for Investors→06FemTech 2.0: From Pink Apps to Women’s Health Infrastructure with 16–17% CAGR→07Why Women’s Health Remains Underinvested: The Gap Between Market Size and Capital Deployed→08Robotic Surgery After da Vinci: New Players and Investment Strategies in Endoluminal and Micro-Segments→09Investor Note: Why Interventional and Minimally Invasive Technologies Are Becoming a PE Priority in 2026→10AI Drug Discovery and Organ-on-a-Chip: How Investors Enter the Sandbox Between Pharma and MedTech→11The Convergence of Biotech and Digital Health: Where Deal Boundaries Are Being Redrawn→12Digital Therapeutics and mHealth: The Shift to Continuous, Behavior-Based Interventions→13The Internet of Medical Things (IoMT) as the Foundation of the Smart Clinic and Remote Monitoring→14Where Deals Will Accelerate: Subsectors Expecting an M&A Surge and Valuation Growth in 2026→
01Medicine 3.0: Why Smart Business Owners Are Rethinking Health→02The Four Horsemen: The Risks Living in Your Body That No Dashboard Is Tracking→03The Highest-ROI Investment a Business Owner Can Make (It’s Not in Your Portfolio)→04The Sleep Debt That’s Costing You More Than You Think→05The Marginal Decade: How Founders Can Design Their Best Years→